Ann: Investor Webinar, page-210

@thurston4pm ....

I have answered his questions several times, but he just comes back re-asking the same things over and over.

It is clear from the JORC guidelines that I linked to that all reporting of reserves is just fine. I even quoted the particular passage for him in a previous post, but he just comes back and re-questions the same things, so what is the point of repeating things??

I also found that EVERY spodumene company currently supplying the market uses flotation and includes fines for delivery to battery converters. The battery converters use all this material, they do not have an issue with it, which is why they are in the data room looking at our data.
They wouldn't be there if there was an issue with our product, so his questions about 'product' became totally irrelevant, with the knowledge of major companies being in our data room, yet he continues to carry on.

The posting is totally not genuine as AVZ , the company he holds, called reserves, resources on p7 of there presentation the other day, yet he didn't say a word about it. He comes here and continually makes mistakes about how reserves are reported, despite AVZ reporting them exactly the same way, but never a word of complaint there!!

Over the next few weeks/months the board will receive some type of offers from different companies about Goulamina, however in the mean time we will have chosen an investment bank to work out the best way to divest lithium from gold in the interests of shareholders.

The announcements coming in those weeks and months ahead are what is important. Now apart from positive gold announcements to look forward to, we also have lithium announcements in there, so lots of positive information coming for months and probably into the next year or 2.

The Firefinch world has moved way beyond any of the questions that @rainbowdaisy keeps posting about. His views are out of date by a long way as the DFS covered all the important issues. The SS he carries on about is past history and not relevant, as those in the data room can make up their own minds now, viewing everything. As Dr Cowden said yesterday, they wouldn't be there if there were any issues with product quality, so questions about this are irrelevant.